Conservation and variability of hepatitis B core at different chronic hepatitis stages

Table 3 Relative frequencies of nucleotide insertions/deletions detected

Clinical stage (n/total)	Patient	Relative frequency (% of mutated haplotypes)
		1951 (1 nt: T)	2085 (1 nt: G)
CHB (8/16)	1	8.36 (8.7)
	2		17.12 (40)
	3		3.19 (5)
	4	0.37 (5.9)
	9	2.02 (8.82)
	10		1.34 (50)
	12		1.04 (10)
	13	2.79 (22.22)
HCC (2/17)	28		0.78 (4)
	33		2.42 (4.8)
LC (1/5)	34		17.42 (19.2)

The table shows the relative frequency of insertions/deletions, together with the percentage (%) of mutated haplotypes per patient. Only patients carrying these mutations were included in the table. CHB: Chronic hepatitis B infection without liver damage; HCC: Hepatocellular carcinoma; LC: Liver cirrhosis; T: Thymine; G: Guanine; nt: Nucleotide.